Recordati SpA (REC) EUR0.125

Sell:€57.85Buy:€59.25€0.85 (1.46%)

Prices delayed by at least 15 minutes
Sell:€57.85
Buy:€59.25
Change:€0.85 (1.46%)
Deal now
Prices delayed by at least 15 minutes
Sell:€57.85
Buy:€59.25
Change:€0.85 (1.46%)
Prices delayed by at least 15 minutes
Deal now

Company Information

About this company

Recordati Industria Chimica e Farmaceutica SpA is an Italy-based group engaged in the research, development, manufacture and marketing of pharmaceuticals. It promotes a wide range of pharmaceuticals, both proprietary and under license, in a number of therapeutic areas, such as Antibiotics and Antiviral, Cardiovascular, Central nervous system, Dermatological, Gastroenterology, Genital-urinary system, Muscular-skeletal disorders and pain therapy, Obstetrics and Gynecology and over the counter (OTC) pharmaceuticals. The Company is engaged in the research and development of new drug entities within the cardiovascular and urogenital therapeutic areas and of treatments for rare diseases. It’s product is ZANIDIP, a latest generation calcium-channel blocker for the treatment hypertension. It operates through Italchimici SpA, Pro Farma AG and North American marketing rights to Cystadane. The Company owns and operates through Natural Point srl also in the food supplement sector.

Key people

Robert Koremans
Chief Executive Officer, Executive Director
Luigi La Corte
Chief Financial Officer, Executive Director
Gabriele Finzi
Executive Vice President - Corporate Development, Licensing and Innovation
Alberto Martinez
Executive Vice President - Specialty and Primary Care Business Unit
Scott Pescatore
Executive Vice President - Rare Disease Business Unit
Roberto Teruzzi
Executive Vice President - Group Industrial Operations
Milan Zdravkovic
Executive Vice President - Research and Development
Giorgio De Palma
Executive Director
Giampiero Mazza
Executive Director
Cathrin Petty
Executive Director
Andrea Recordati
Non-Executive Chairman of the Board
Guido Guidi
Non-Executive Vice Chairman of the Board
Michaela Castelli
Lead Independent Non-Executive Director
Kim Stratton
Non-Executive Director
Elisa Corghi
Non-Executive Independent Director
Click to see more

Key facts

  • EPIC
    -
  • Location
    Italy
  • Sector
    Healthcare
  • Industry
    Biotechnology & Drugs
  • ISIN
    IT0003828271
  • Market cap
    €12.16bn
  • Employees
    4,455
  • Shares in issue
    209.06m
  • Exchange
    Italian SE (Mercato Continuo Italia)
  • Index
  • Website
    Visit website

Data policy - All information should be used for indicative purposes only. You should independently check data before making any investment decision. HL cannot guarantee that the data is accurate or complete, and accepts no responsibility for how it may be used. Overview data is sourced from Refinitiv.